News and analysis on disease research and diagnostics.
A partnership with Menarini Silicon Biosystems to market Menarini’s portfolio of COVID-19 related products was among its key quarterly milestones.
Although the firm has ramped up COVID-19 testing, its billable test volume and overall testing revenues both declined due to pandemic-related challenges to its core oncology business.
The Singapore-based immune profiling firm aims to open a US facility by the end of the year and begin running projects out of it in the first quarter of 2021.
Researchers followed a cohort of soldiers deployed to Honduras for signs of gastrointestinal illness and analyzed their gut microbiomes.
GeneCentric's RNA-based molecular profiling platform will identify relevant non-muscle invasive bladder cancer subtypes and markers for potential therapeutic options.
